![Paul Townsend](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Townsend
No más puestos en curso
Perfil
Paul Townsend is the founder of Karus Therapeutics Ltd.
which was founded in 2005.
He also worked as a Non-Executive Director at Aptamer Group Plc.
Mr. Townsend received an undergraduate degree from York University.
Antiguos cargos conocidos de Paul Townsend.
Empresas | Cargo | Fin |
---|---|---|
APTAMER GROUP PLC | Director/Miembro de la Junta | - |
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Fundador | - |
Formación de Paul Townsend.
York University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
APTAMER GROUP PLC | Health Technology |
Empresas privadas | 1 |
---|---|
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Paul Townsend